Update: 24.10.2022
Last week: 41 week 2022 (10.10.2022 - 16.10.2022)
Last full month: September 2022
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE BERLIN-CHEMIE | |||||||||
| WoW | 147 280 | -13.4% | 3.8% | -0.2 | 31 585 542 | -10.7% | 3.9% | -0.1 | -9.8% |
| MoM | 747 528 | 79.1% | 3.7% | 0 | 153 590 034 | 85.1% | 3.8% | 0.1 | 81.0% |
| YTD | 8 046 972 | -13.3% | 5.4% | -0.9 | 1 600 815 412 | 2.0% | 5.2% | -0.5 | 1.2% |
| MAT | 12 034 484 | 5.1% | 5.7% | 0.2 | 2 322 321 856 | 21.6% | 5.4% | 0.4 | 1.7% |
| DEXALGIN | |||||||||
| WoW | 20 919 | -4.2% | 0.4% | 0 | 10 345 785 | -2.8% | 1.4% | 0 | -3.3% |
| MoM | 90 811 | 16.9% | 0.4% | 0 | 43 312 453 | 19.6% | 1.1% | 0 | 21.7% |
| YTD | 1 390 133 | 5.2% | 0.7% | 0 | 590 034 072 | 17.4% | 1.8% | 0.1 | 2.3% |
| MAT | 1 907 611 | 8.5% | 0.7% | 0.1 | 788 572 857 | 18.9% | 2.0% | 0.1 | 0.8% |
| ESPUMISAN (ADULTS) | |||||||||
| WoW | 52 816 | -7.6% | 41.5% | -1.4 | 27 705 391 | -7.6% | 47.5% | -1.5 | -4.4% |
| MoM | 281 557 | 10.8% | 46.3% | -0.4 | 148 737 462 | 10.9% | 52.0% | -0.6 | 11.7% |
| YTD | 3 683 903 | -9.1% | 55.6% | -10.8 | 1 873 639 831 | 1.7% | 61.1% | -9.4 | 8.6% |
| MAT | 4 911 370 | -3.9% | 57.5% | -8.5 | 2 455 785 050 | 7.5% | 63.0% | -7.2 | 10.3% |
| ESPUMISAN BABY | |||||||||
| WoW | 22 582 | -7.9% | 31.9% | -1.7 | 14 718 331 | -8.5% | 45.3% | -1.7 | -3.1% |
| MoM | 112 687 | 10.3% | 34.9% | -0.1 | 73 791 527 | 12.4% | 48.2% | 0.5 | 10.7% |
| YTD | 1 173 212 | -10.9% | 38.1% | -3.7 | 732 422 799 | -4.5% | 51.3% | -5.3 | -2.3% |
| MAT | 1 519 318 | -11.6% | 38.4% | -3.3 | 937 131 043 | -4.3% | 51.9% | -4.1 | -4.0% |
| FASTUM | |||||||||
| WoW | 14 288 | -3.8% | 0.8% | 0 | 8 112 276 | -3.6% | 2.1% | 0 | -1.9% |
| MoM | 77 456 | 19.6% | 0.9% | 0 | 42 173 280 | 18.5% | 2.2% | 0.1 | 15.2% |
| YTD | 869 299 | -21.6% | 1.1% | -0.3 | 449 035 856 | -11.8% | 2.5% | -0.6 | 1.4% |
| MAT | 1 145 924 | -20.6% | 1.2% | -0.3 | 579 911 975 | -11.5% | 2.6% | -0.6 | 0.7% |
| IODOMARIN | |||||||||
| WoW | 79 039 | -11.3% | 23.3% | -2 | 14 575 615 | -11.1% | 9.8% | -1.3 | -3.8% |
| MoM | 335 689 | 32.6% | 24.3% | 2.3 | 62 171 772 | 28.4% | 10.7% | 1 | 20.3% |
| YTD | 2 538 538 | 7.4% | 20.0% | 0.1 | 500 552 686 | 12.7% | 9.0% | 0 | 6.8% |
| MAT | 3 341 870 | 22.9% | 20.7% | 2.5 | 648 662 917 | 24.7% | 9.3% | 1 | 7.7% |
| LIOTON | |||||||||
| WoW | 15 886 | -1.0% | 1.7% | 0 | 17 744 279 | 2.4% | 3.9% | 0.2 | -0.3% |
| MoM | 83 625 | -9.1% | 1.8% | -0.2 | 90 280 193 | -8.4% | 3.9% | -0.4 | 1.3% |
| YTD | 1 079 059 | -22.4% | 2.3% | -0.5 | 1 106 842 149 | -2.7% | 4.7% | -0.9 | -6.4% |
| MAT | 1 379 908 | -19.3% | 2.4% | -0.4 | 1 371 626 224 | -0.5% | 4.8% | -0.7 | -6.4% |
| MEZYM | |||||||||
| WoW | 206 500 | -5.1% | 18.9% | 0 | 31 113 540 | -8.7% | 13.4% | -0.5 | -5.1% |
| MoM | 1 012 478 | 8.5% | 18.9% | -0.8 | 154 387 022 | 9.1% | 13.4% | -0.5 | 13.2% |
| YTD | 14 911 050 | -3.0% | 27.0% | -1 | 2 281 210 390 | 6.1% | 19.3% | -1.6 | 0.5% |
| MAT | 20 290 571 | 3.6% | 28.3% | 0.4 | 3 040 038 636 | 11.2% | 20.4% | -0.6 | 2.1% |
| MIG 400 | |||||||||
| WoW | 133 697 | -4.8% | 2.8% | 0 | 16 201 468 | -4.3% | 2.2% | 0 | -3.3% |
| MoM | 705 306 | 16.2% | 2.8% | -0.1 | 83 916 288 | 16.1% | 2.2% | 0 | 21.7% |
| YTD | 6 911 555 | -11.0% | 3.4% | -0.5 | 813 671 879 | -7.0% | 2.5% | -0.5 | 2.3% |
| MAT | 9 032 634 | -6.0% | 3.4% | -0.2 | 1 055 606 314 | -2.0% | 2.6% | -0.3 | 0.8% |
| PROSTAMOL | |||||||||
| WoW | 23 614 | -18.0% | 15.6% | -2.1 | 32 136 826 | -19.5% | 16.4% | -2.4 | -7.0% |
| MoM | 107 142 | 27.2% | 15.1% | 0 | 149 162 441 | 25.9% | 16.1% | 0.2 | 27.1% |
| YTD | 1 294 187 | -23.0% | 19.3% | -5.8 | 1 814 143 989 | -14.0% | 20.6% | -6.8 | 0.1% |
| MAT | 1 752 451 | -18.4% | 20.1% | -4.5 | 2 405 479 208 | -10.2% | 21.5% | -5.5 | -0.1% |
| RESPERO MYRTOL | |||||||||
| WoW | 21 872 | -23.1% | 7.5% | -1.8 | 10 669 497 | -23.5% | 7.8% | -1.8 | -4.1% |
| MoM | 111 511 | 68.8% | 7.7% | -1.4 | 53 402 083 | 71.8% | 8.0% | -1.2 | 99.0% |
| YTD | 989 396 | 125.6% | 8.8% | 4.8 | 463 861 288 | 124.3% | 8.7% | 4.3 | 3.6% |
| MAT | 1 297 579 | 120.6% | 8.6% | 4.5 | 601 931 184 | 115.5% | 8.5% | 3.9 | 5.9% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 8 046 972 | -13.3% | 5.4% | -0.9 | 1 600 815 412 | 2.0% | 5.2% | -0.5 | 1.2% |
| DEXALGIN | 1 390 133 | 5.2% | 0.7% | 0 | 590 034 072 | 17.4% | 1.8% | 0.1 | 2.3% |
| ESPUMISAN (ADULTS) | 3 683 903 | -9.1% | 55.6% | -10.8 | 1 873 639 831 | 1.7% | 61.1% | -9.4 | 8.6% |
| ESPUMISAN BABY | 1 173 212 | -10.9% | 38.1% | -3.7 | 732 422 799 | -4.5% | 51.3% | -5.3 | -2.3% |
| FASTUM | 869 299 | -21.6% | 1.1% | -0.3 | 449 035 856 | -11.8% | 2.5% | -0.6 | 1.4% |
| IODOMARIN | 2 538 538 | 7.4% | 20.0% | 0.1 | 500 552 686 | 12.7% | 9.0% | 0 | 6.8% |
| LIOTON | 1 079 059 | -22.4% | 2.3% | -0.5 | 1 106 842 149 | -2.7% | 4.7% | -0.9 | -6.4% |
| MEZYM | 14 911 050 | -3.0% | 27.0% | -1 | 2 281 210 390 | 6.1% | 19.3% | -1.6 | 0.5% |
| MIG 400 | 6 911 555 | -11.0% | 3.4% | -0.5 | 813 671 879 | -7.0% | 2.5% | -0.5 | 2.3% |
| PROSTAMOL | 1 294 187 | -23.0% | 19.3% | -5.8 | 1 814 143 989 | -14.0% | 20.6% | -6.8 | 0.1% |
| RESPERO MYRTOL | 989 396 | 125.6% | 8.8% | 4.8 | 463 861 288 | 124.3% | 8.7% | 4.3 | 3.6% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 12 034 484 | 5.1% | 5.7% | 0.2 | 2 322 321 856 | 21.6% | 5.4% | 0.4 | 1.7% |
| DEXALGIN | 1 907 611 | 8.5% | 0.7% | 0.1 | 788 572 857 | 18.9% | 2.0% | 0.1 | 0.8% |
| ESPUMISAN (ADULTS) | 4 911 370 | -3.9% | 57.5% | -8.5 | 2 455 785 050 | 7.5% | 63.0% | -7.2 | 10.3% |
| ESPUMISAN BABY | 1 519 318 | -11.6% | 38.4% | -3.3 | 937 131 043 | -4.3% | 51.9% | -4.1 | -4.0% |
| FASTUM | 1 145 924 | -20.6% | 1.2% | -0.3 | 579 911 975 | -11.5% | 2.6% | -0.6 | 0.7% |
| IODOMARIN | 3 341 870 | 22.9% | 20.7% | 2.5 | 648 662 917 | 24.7% | 9.3% | 1 | 7.7% |
| LIOTON | 1 379 908 | -19.3% | 2.4% | -0.4 | 1 371 626 224 | -0.5% | 4.8% | -0.7 | -6.4% |
| MEZYM | 20 290 571 | 3.6% | 28.3% | 0.4 | 3 040 038 636 | 11.2% | 20.4% | -0.6 | 2.1% |
| MIG 400 | 9 032 634 | -6.0% | 3.4% | -0.2 | 1 055 606 314 | -2.0% | 2.6% | -0.3 | 0.8% |
| PROSTAMOL | 1 752 451 | -18.4% | 20.1% | -4.5 | 2 405 479 208 | -10.2% | 21.5% | -5.5 | -0.1% |
| RESPERO MYRTOL | 1 297 579 | 120.6% | 8.6% | 4.5 | 601 931 184 | 115.5% | 8.5% | 3.9 | 5.9% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 147 280 | -13.4% | 3.8% | -0.2 | 31 585 542 | -10.7% | 3.9% | -0.1 | -9.8% |
| DEXALGIN | 20 919 | -4.2% | 0.4% | 0 | 10 345 785 | -2.8% | 1.4% | 0 | -3.3% |
| ESPUMISAN (ADULTS) | 52 816 | -7.6% | 41.5% | -1.4 | 27 705 391 | -7.6% | 47.5% | -1.5 | -4.4% |
| ESPUMISAN BABY | 22 582 | -7.9% | 31.9% | -1.7 | 14 718 331 | -8.5% | 45.3% | -1.7 | -3.1% |
| FASTUM | 14 288 | -3.8% | 0.8% | 0 | 8 112 276 | -3.6% | 2.1% | 0 | -1.9% |
| IODOMARIN | 79 039 | -11.3% | 23.3% | -2 | 14 575 615 | -11.1% | 9.8% | -1.3 | -3.8% |
| LIOTON | 15 886 | -1.0% | 1.7% | 0 | 17 744 279 | 2.4% | 3.9% | 0.2 | -0.3% |
| MEZYM | 206 500 | -5.1% | 18.9% | 0 | 31 113 540 | -8.7% | 13.4% | -0.5 | -5.1% |
| MIG 400 | 133 697 | -4.8% | 2.8% | 0 | 16 201 468 | -4.3% | 2.2% | 0 | -3.3% |
| PROSTAMOL | 23 614 | -18.0% | 15.6% | -2.1 | 32 136 826 | -19.5% | 16.4% | -2.4 | -7.0% |
| RESPERO MYRTOL | 21 872 | -23.1% | 7.5% | -1.8 | 10 669 497 | -23.5% | 7.8% | -1.8 | -4.1% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 747 528 | 79.1% | 3.7% | 0 | 153 590 034 | 85.1% | 3.8% | 0.1 | 81.0% |
| DEXALGIN | 90 811 | 16.9% | 0.4% | 0 | 43 312 453 | 19.6% | 1.1% | 0 | 21.7% |
| ESPUMISAN (ADULTS) | 281 557 | 10.8% | 46.3% | -0.4 | 148 737 462 | 10.9% | 52.0% | -0.6 | 11.7% |
| ESPUMISAN BABY | 112 687 | 10.3% | 34.9% | -0.1 | 73 791 527 | 12.4% | 48.2% | 0.5 | 10.7% |
| FASTUM | 77 456 | 19.6% | 0.9% | 0 | 42 173 280 | 18.5% | 2.2% | 0.1 | 15.2% |
| IODOMARIN | 335 689 | 32.6% | 24.3% | 2.3 | 62 171 772 | 28.4% | 10.7% | 1 | 20.3% |
| LIOTON | 83 625 | -9.1% | 1.8% | -0.2 | 90 280 193 | -8.4% | 3.9% | -0.4 | 1.3% |
| MEZYM | 1 012 478 | 8.5% | 18.9% | -0.8 | 154 387 022 | 9.1% | 13.4% | -0.5 | 13.2% |
| MIG 400 | 705 306 | 16.2% | 2.8% | -0.1 | 83 916 288 | 16.1% | 2.2% | 0 | 21.7% |
| PROSTAMOL | 107 142 | 27.2% | 15.1% | 0 | 149 162 441 | 25.9% | 16.1% | 0.2 | 27.1% |
| RESPERO MYRTOL | 111 511 | 68.8% | 7.7% | -1.4 | 53 402 083 | 71.8% | 8.0% | -1.2 | 99.0% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "BROMHEXINE B-CH"## [1] "BROMHEXINE B-CH COATED TABLETS 8 MG #25"## [1] "BROMHEXINE B-CH SOL ORAL 4 MG/5 ML 60 ML #1"## [1] "ESPUMISAN (ADULTS)"## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #25"## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #50"## [1] "ESPUMISAN (ADULTS) EXTRA GRAN 125 MG #14"## [1] "ESPUMISAN (ADULTS) L EMULS ORAL 40 MG 30 ML #1"## [1] "ESPUMISAN BABY"## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 30 ML #1"## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 50 ML #1"## [1] "FASTUM"## [1] "FASTUM GEL FOR EXT USE 2,5% 100 G #1"## [1] "FASTUM GEL FOR EXT USE 2,5% 30 G #1"## [1] "FASTUM GEL FOR EXT USE 2,5% 50 G #1"## [1] "LIOTON"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 100 G #1"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 30 G #1"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 50 G #1"## [1] "MEZYM"## [1] "MEZYM 20000 INTESTINAL-SOLUBLE COATED TABLETS #20"## [1] "MEZYM FORTE COATED TABLETS #20"## [1] "MEZYM FORTE COATED TABLETS #80"## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #20"## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #50"## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #20"## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #50"## [1] "MEZYM PRO INTESTINAL-SOLUBLE COATED TABLETS #20"## [1] "DEXALGIN"## [1] "DEXALGIN 25 COATED TABLETS 25 MG #10"## [1] "MIG 400"## [1] "MIG 400 COATED TABLETS 400 MG #10"## [1] "MIG 400 COATED TABLETS 400 MG #20"## [1] "PROSTAMOL"## [1] "PROSTAMOL UNO CAPS 320 MG #30"## [1] "PROSTAMOL UNO CAPS 320 MG #60"## [1] "PROSTAMOL UNO CAPS 320 MG #90"## [1] "IODOMARIN"## [1] "IODOMARIN 100 TABS 100 MCG #100"## [1] "IODOMARIN 200 TABS 200 MCG #100"## [1] "IODOMARIN 200 TABS 200 MCG #50"## [1] "IODOMARIN FOR THE FUTURE MOTHER TABLETS 140 MG #30"## [1] "RESPERO MYRTOL"## [1] "RESPERO MYRTOL CAPS ENTEROSOLUB 120 MG #20"## [1] "RESPERO MYRTOL FORTE CAPS ENTEROSOLUB 300 MG #20"[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs
MI: Fact Digital Costs
MI Estimated Costs: TV costs